Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.15 USD
-0.04 (-1.83%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.15 0.00 (0.00%) 7:30 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Earnings News For TSHA
-
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Lags Revenue Estimates
-
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates
-
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
-
Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
-
Taysha Gene Therapies Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial and Provides Corporate Update with Second Quarter 2023 Financial Results
-
Taysha Gene Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
Taysha Gene Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update